More Info

Sheraton Philadelphia University City
3549 Chestnut Street
Philadelphia, PA 19104
United States

DESCRIPTION

Maximizing Investigator Meetings
Investigator meetings are essential to successfully train clinical sites as they directly affect a sponsor’s ability to collect accurate safety and efficacy data. A well-executed investigator meeting cultivates a crucial team atmosphere and is an opportunity for sites and sponsors to discuss the protocol, regulatory issues, enrollment criteria, and procedures. Having the opportunity to discuss protocol specific subjects directly with the sponsor is of great value for clinical sites.

It is important is to communicate all essential information in the most time-efficient and engaging manner. Expert collaboration between the sponsor’s clinical teams, meeting professionals, and vendors is required to execute productive and enjoyable investigator meetings.

Investigator buy-in on the study objectives and well-trained clinical sites, confident in their ability to conduct the newly introduced study, are the hallmark of a successful investigator meeting. This event will serve as a platform to discuss strategies to streamline in person or virtual investigator meetings, without forfeiting content. ExL’s Maximizing Investigator Meetings conference is the industry’s only conference for the clinical teams, meeting planners, and solution providers that collaborate to bring investigator meetings to fruition.

Who Should Attend

This conference is designed for representatives from pharmaceutical, medical device, and biotechnology companies with responsibilities in the following areas:

Determine meeting structures to build a sense of community and investigator buy-in while communicating essential regulatory and clinical information
Strategies to virtually engage investigators and research coordinators
Create uncommon opportunity for KOLs and clinical site staff to engage about the protocol details
Deciding between virtual and in-person meetings
Identify Ways to Facilitate Discussion When the Crowd Is Timid

In person Investigator Meetings can often lead to protocol amendments. It is essential to create a meeting structure where site and pick the brain of the sponsor and bring their expertise to study.

Heidi Cocca has been at Merck for more than 10 years, working on various aspects of the clinical trial process, including training investigative sites. In 2008, she joined the newly formed meeting management department with a goal to develop, implement and sustain a new meeting model that produces compliant, cost-effective and high-quality investigator meetings. Prior to joining Merck, Heidi worked in software development, and now brings that zeal for technology to her current meetings, through digital and hybrid meetings, and stays on top of the latest trends such as meeting applications and gamification.

Heidi received her undergraduate degree from Lynchburg College and now lives outside of Philadelphia with her husband and two boys.